Surgical Instruments Brand Ranking

Longkou Kangxie Medical Instrument Co., Ltd

we are a high-tech enterprise specializing in the research, production and sales of X-ray protection products. The company occupies an area of 8,000 square meters, well-equipped, complete testing, with strong technical energy, owns 120 employees including 30 engineering and technical personnel, the company was established in 2006, the production products include: medical X-ray protection products, medical X-ray protection Skirts, protective gloves, protective screens, protective chairs, protective glasses, protective masks, traction straps, medical oxygen bags, medical air cushions, anal bags, etc.

Alcon (China) Ophthalmic Products Co., Ltd.

Alcon is a global leader in the field of ophthalmic health care, focusing on helping people see a brighter world. With a history of more than 75 years, Alcon is one of the world's largest ophthalmic nursing equipment companies, with complementary business advantages in surgical products and vision care. In 1945, two pharmacists, Robert Alexander and William Conner, opened a small pharmacy in Fort Worth, Texas, and combined the syllables of their last name into the pharmacy name "Alcon". Alcon has achieved its position in the ophthalmology field through innovative and breakthrough technologies, and has improved the way people treat eye diseases and improve vision. Alcon has a wealth of ophthalmic products in the industry, divided into two major business areas: ophthalmic surgery and vision care. Alcon provides a wide range of ophthalmic surgical products that can cover the entire life cycle of ophthalmic diseases, helping doctors achieve better treatment results. The product portfolio includes advanced technology intraocular lenses, comprehensive refractive cataract platform, digital vitreous retinal surgery platform and visual quality refractive integrated platform. Alcon's high-quality contact lenses and care liquid products can meet the needs of all kinds of consumers. Contact lens products include transparent daily throwing, color daily throwing and monthly throwing contact lenses. Contact lens care liquid and eye moisturizing products can bring consumers a lasting and comfortable wearing experience. In addition, the Alcon family of artificial tears products can help alleviate the increasingly severe symptoms of dry eyes.

NINGBO RAYCAREMED MEDICAL INSTRUMENTS CO., LTD

Ningbo Raycaremed Medical Instruments Co.,Ltd is one of the professional supplier for the Medical Instrument products in China. Our Team has more than 10 years experiences in Medical field. We export our products to customers in Europe, Africa, Asia and America. We are factory ,located in Jiangsu province,which near Shanghai port, we produce Syringe, infusion set, Gloves and Face mask. In order to fulfill and increasing needs of our trusted and loyal customers,apart from our factory ,we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing syringes diagnostics & lab products. We care the success of our customers,we know that the important of quality,so we set up a strong QC team stay in differences production lines to ensure & control quality. Our Company is approved by CE&ISO certificates for most of products. In future, Raycaremed Medical will keep high effcient and professional for every customer, and associating company development with human health. We will keep putting love and respect into our every product all the way, and do our best effort to bring health to everyone at the world.

Shandong Zhushi Pharmaceutical Group Co.,LTD

Shandong Zhushi Pharmaceutical Group is located in China. It has been in the industry of Medical Devices for over 20 years now. Our company presents innovative products to you that including Medical Devices (Epidemic Prevention Products, Medical consumables, Medical Plaster & Medical Gel Products), Skin Care and Cosmetics, Health Food Products, etc.

Stryker (Beijing) Medical Devices Co., Ltd.

As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.

Enochon Medical Technology (Suzhou) Co., Ltd.

Enukang Medical Technology (Suzhou) Co., Ltd. was established in 2014 and was jointly founded by many overseas returnees and senior professionals in the domestic medical industry. It is a Jiangsu Province dual-innovation talent enterprise, a Gusu leading talent enterprise and a park leading talent enterprise. The company was selected as a listed nursery project in Suzhou Industrial Park in 2020 and passed the national high-tech enterprise certification in 2021. The company is headquartered in the Suzhou area of ​​China (Jiangsu) Free Trade Pilot Zone. It has a production base and some R&D cooperation projects in Hefei, and a R&D center in California, USA. In the field of high-end medical devices, the company has independent research and development teams and core technologies for ultrasonic energy platforms, electrosurgical energy platforms, ophthalmic devices and minimally invasive surgical robots, and is committed to high-end ultrasonic, energy surgery, ophthalmology and laparoscopic surgical robots and other surgical instrument systems. The research and development, production, sales and service of high-value consumables, and independent innovation of core technologies is used as a key factor in enhancing the company's core competitiveness, attaching great importance to intellectual property protection. Up to now, the company has applied for 220 domestic patents and 50 international patents.

Beijing Anhe Galil Technology Co., Ltd.

Beijing Anhe Galier Technology Co., Ltd. was established in 2012 and is located in Building 18, Dazu Enterprise Bay, No. 8 Liangshuihe Second Street, Beijing Economic and Technological Development Zone. The company currently has more than 200 employees and a construction area of ​​7,500 square meters, including clean and non-clean production areas, with a clean area of ​​about 900 square meters, and has a 100,000-level purification production workshop, a 10,000-level sterile laboratory, a microbial laboratory and a positive control room. , and has configured and built a purified water water production system to meet the standards of research, development, production and inspection of active equipment and sterile medical device products. The existing products are AH-600 ultrasonic scalpel system, ultrasonic air pressure ballistic gravel clearing system, percutaneous renal puncture kit and AH-2000 disposable soft endoscope high-frequency surgical instruments, with a total of more than 40 products. patent. AH-600 ultrasonic scalpel system mainly includes host, transducer, handle, disposable tool, foot switch, and clinical departments for application include general surgery, gynecology, urology, thoracic surgery, pediatric surgery, otolaryngology, plastic surgery Surgery, used for cutting, separation, and hemostasis in laparoscopic and open surgery. Beijing Anhe Galier Technology Co., Ltd. aims to provide hospitals and medical insurance with more than 500 Grade A hospitals including Peking Union Medical College Hospital, Peking University First Hospital, and Shanghai Changhai Hospital. Long-term and stable customer relationships. The UltraSmash™ integrated gravel clearing system independently developed by Anhe Galill Company creatively integrates a variety of gravel methods, equipped with pre-, post- and post-operative equipment and consumables, providing convenient integration for urologists. PNL and URL solutions. Anhe Galill Company has always been committed to promoting the health cause, advocating caring for public health, and will continue to innovate and pursue higher quality products, and is committed to building the company into a surgical instrument platform company.

Medtronic (Shanghai) Management Co., Ltd.

Covidien, one of the world's earliest providers of medical solutions, dates back to G. Mallinckrodt & Company, founded in St. Louis, Missouri, USA in 1867. In 2007, Tyco Medical was renamed Covidien and was independently listed in the United States. "Co" and "Vi" in the brand name come from Latin, meaning common and life. Tyco Healthcare is an important part of Tyco International Group and is a major global manufacturer of medical equipment and disposable medical products. Tyco Medical's main business includes four major business departments: medical devices, imaging, medicines, and medical supplies. As one of the world-class suppliers of the global healthcare industry, its products are sold to more than 130 countries and regions. Tyco Medical’s mission provides medical staff around the world with excellent and innovative medical products, allowing patients to enjoy high-quality medical services. Since entering China in 2000, Tyco Medical has been committed to promoting a full range of advanced technologies to help improve China's medical care level. Through close cooperation with dealers across the country, Tyco is dedicated to training customers to help customers master advanced technology in order to reduce the overall medical costs of patients and provide better medical services.

Medtronic (Shanghai) Management Co., Ltd.

Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson Medical Technology’s global history can be traced back to the beginning of Johnson & Johnson’s establishment in the United States in 1886. As one of the healthcare companies with wide business worldwide, Johnson & Johnson originated from the production of sterile surgical sutures and auxiliary materials. For more than a century, Johnson & Johnson Medical Technology has always been committed to becoming a world-leading medical technology innovator and bringing far-reaching significance to human health with rich and diverse professional accumulation, mission-significant scientific innovation, and high enthusiasm for human health. Influence, let people all over the world have a healthy and beautiful life. At present, in the fields of surgery, cardiovascular and professional solutions, orthopedics and ophthalmology, Johnson & Johnson Medical Technology continues to innovate and deepen its efforts around the world, striving to solve unmet medical needs, reimagine the future of human health, and allow medical solutions to Smarter, more minimally invasive, more personalized, protect life and light up every beam of hope. In 1994, Johnson & Johnson Medical Technology entered the Chinese market. Currently, Johnson & Johnson Medical Technology has more than 5,000 employees in China, of which 85% are new generation employees. It is headquartered in Shanghai and has offices in Beijing, Guangzhou and other places. On the road of growing together with China's medical and health industry, we will continue to expand and improve our product layout and supply chain production capacity in China. At present, medical technology has become Johnson & Johnson's largest business segment in China. In recent years, Johnson & Johnson Medical Technology has continued to deepen its layout of end-to-end supply chain systems in China, improve local intelligent manufacturing capabilities, introduce global advanced product, technology and quality management experience, and help the industry develop at a high quality and high speed. The integrated supply chain production base located in Suzhou Industrial Park is a large comprehensive industrial park of Johnson & Johnson Medical Technology in China. It integrates the research and development and manufacturing of medical equipment, technological innovation and cooperation, global shared services, regional procurement and supplier management. and other diversified business functions, among which the intelligent manufacturing factory produces a series of innovative products such as surgery and orthopedics, responds to local demand and supplies globally. Johnson & Johnson Medical Technology not only focuses on cultivating and upgrading local intelligent manufacturing capabilities, but also further focuses on local R&D and innovation capabilities. In addition to Suzhou Supply Chain Base, Guangzhou Beixiu Biotechnology Co., Ltd., a wholly-owned subsidiary of Johnson & Johnson, is a biotechnology company specializing in technology development, research and production of pig-derived biological products. Beixiu independently developed the technology to extract fibrinogen and thrombin from mammalian blood, which is the world's first biomedical innovation. On the road to growing together with China's medical and healthcare industry, Johnson & Johnson Medical Technology has deepened the professional education and training of Chinese professional medical staff and is committed to becoming a trustworthy partner of Chinese medical staff. In line with the purpose of "exploring human technology and caring about human health", three Johnson & Johnson Medical Technology Professional Education Academic Centers located in Beijing, Shanghai and Boao Lecheng Medical Pilot Zone and the digital doctor training and education platform "Ling Yimai" provide professional knowledge, Training to adapt to China's medical service environment and innovative medical education forms will be promoted to the professional and systematic development of continuing medical education. In addition, Johnson & Johnson Medical Technology is also actively working with partners from all walks of life to promote innovation cooperation, accelerate the transformation of innovative results, and serve patients. As part of Johnson & Johnson's China Innovation Engine Strategy, Johnson & Johnson cooperates with local companies to leverage digital technologies such as artificial intelligence, surgical robots, and big data to assist doctors in more effective perioperative work and establish localized digital surgical solutions.

Ningbo Yaoming Medical Technology Co., Ltd.

Ningbo Yaoming Medical Technology Co., Ltd. is located in Ningbo City, Zhejiang Province, on the coast of the East China Sea.Yaoming Medical Technology Company has always prioritized research and innovation as its foundation, sales channels as its basis, digital solutions as its guide, and clinic terminal demands as its orientation. The company adheres to the principles of scientific development and people-oriented approach, boasting a comprehensive management team, robust technical team, stable sales team, and distribution channels.lt has established deep collaborations with relevant hospitals, frontline doctorsand universities, among others, to enhance the "industry-university-research-application" independent innovation model and foster synergistic innovation to empower industry development.Yaoming Medical has always been at the forefront of exploration in the field of minimally invasive surgical instruments and accessories(MISIA),particularly in the MISIA market.With a focus on products such as carbon dioxide insufflators and disposable sterile trocar systems for laparoscopic insufflation,we has achieved significant breakthroughs in technology after long-term research and development efforts.It has successfully overcome technological barriers from foreign sources and pioneered the development of a brand-new laparoscopic insufflation system. After multiple rounds of testing, the performance of the system is on par with high-end foreign products.We has always been dedicated to technological innovation, aiming to provide excellent and comprehensive solutions in the field of minimally invasive surgical instruments for doctors and patients alike.lts commitment extends to expanding the path of the global minimally invasive surgical medical deviceindustry in China.

Weigao Group Co., Ltd.

Weigao was founded in 1988. With the simple and kindness of improving the lives of the elderly and widowed, he set up a small workshop in the township welfare home. Currently committed to developing its main business medical devices and medicine, covering an area of ​​more than 6 million square meters, it has 13 industrial groups and more than 100 subsidiaries, including 3 listed companies and 8 overseas companies, and is located in 10 provinces and cities in China. A manufacturing base is built with more than 30,000 employees. We have always taken improving national health and breaking foreign monopoly as our mission. We have now become a global supplier of comprehensive, safe, reliable and trustworthy overall solutions for medical systems. Create a systematic R&D platform to enhance core competitiveness through innovation and enrich product structure. 15 national and provincial innovation platforms have been built, including the National Certified Enterprise Technology Center, National Engineering Research Center, National Innovation Pilot Enterprise, Academician Workstation, Postdoctoral Workstation, Taishan Scholar Laboratory, etc., and many other institutions, including the Chinese Academy of Sciences, the Chinese Academy of Engineering, 301 Hospital, etc. Our unit has carried out industry-university-research cooperation and established cooperative relationships with more than 100 academicians. It has more than 1,700 patents, more than 1,000 medical devices and drugs, and more than 200,000 specifications. Committed to solving the "bottleneck" problem in foreign countries, overcome 21 technical barriers, achieve domestic substitution for more than 100 products, undertake more than 30 national key projects, win 4 national scientific and technological progress awards, 2 national technological invention awards, and national excellent industry 1 gold medal in design. Adhere to scientific management and improve the management system. It has a national technical standard innovation base and a national certification and testing center, and has 1 international standards formulated by enterprises in the industry and 2 international standards proposals, leading or participating in 11 national standards. Improve product quality with advanced manufacturing technology, introduce advanced domestic and foreign automated production equipment, establish management systems such as intelligent manufacturing (MES), AI visual inspection, quality BI data, etc., continuously improve management and control processes, and carry out digital transformation to continuously improve production and manufacturing capabilities and Management level. Improve industrial layout, lay out chains, strengthen chains, and extend chains. Establish an industrial layout of the coordinated development of three types of business formats to create a medical ecological chain. The medical industry has focused on creating product lines such as clinical nursing, orthopedics, blood purification, drug packaging, medical intervention, surgical robots, and medical engineering. It ranks among the top in the country in terms of product lines such as nursing, hemodialysis, pharmaceutical packaging materials, and blood technology. The sales network is spread all over the country and abroad, with more than 100 sales offices, and has created the "Jierui" and "Vigao" brands, and its products are sold to more than 100 countries or regions around the world.

Changzhou Weipu Medical Devices Co., Ltd.

Changzhou Weipu Medical Devices Co., Ltd. is located in Xinbei District Changzhou City, in the Golden Triangle of the Yangtze River, here we have superior geographical location and convenient transportation.The company covers an area of over 20000 square meters and is dedicated to the research and development, production, sales, and service of medical devices. As one of the largest OEM manufacturer in China, we achieve full inspection of each product and specification, with a large workload every time. We have a strong commitment to healthcare professionals, and we are proving it every day. Although it is time-consuming and labor-intensive, and increases costs, the quality reputation of Weipu brand has won recognition from the market and customers. Our company adheres to the corporate philosophy of "customer first, technological innovation, reliable quality", and has a large number of professional talents, laying a solid foundation for the company to continuously surpass and pursue better goals. The company actively follows the ISO13485 quality management system, strictly manages quality, ensures product quality, provides trustworthy products for users, and receives recognition from the majority of users with the most thoughtful service. Healthcare professionals inspire our wound management, prevention and surgical solutions. Their relentless search for new and better ways to care for patients drives us to innovate. And the research and development of new products is the source of maintaining a company's market advantage and competitiveness. Therefore, we always insist on paying tribute to life with innovation, patient safety first and clinical effect first.

Shandong Xinhua Medical Instruments Co., Ltd.

Shandong Xinhua Medical Devices Co., Ltd. was established in 1943 and is an early medical device manufacturer in China. In September 2002, it was listed on the Shanghai Stock Exchange (600587). It is an advanced domestic health industry group integrating medical devices and pharmaceutical equipment scientific research, production, sales, medical services, commerce and logistics. It is the China Medical Device Industry Association. The chief unit, the chairman unit of the National Infection and Control Technology Professional Committee, the chairman unit of the China Radiotherapy Industry Technology Innovation Strategic Alliance, the chairman unit of the China Pharmaceutical Equipment Industry Association, and the chairman unit of the China Pharmaceutical Equipment Engineering Association. In the medical device sector, nine advanced product lines with excellent configuration and complete technology have been formed, covering infection control, radiotherapy and imaging, surgical instruments and orthopedics, operating room engineering and equipment, oral equipment and consumables, in vitro diagnostic reagents and instruments, biology Materials and consumables, dialysis equipment and consumables, medical environmental protection and other fields. At present, the varieties and output of infection control equipment rank among the best in the world ; the research and development and production of radiotherapy equipment is large in China, with a wide variety, with a high domestic market share and an advanced technical level; in the pharmaceutical equipment sector, it consists of biopharmaceuticals, special infusions, traditional Chinese medicine preparations, It is composed of four major engineering and technical centers for solid preparations, integrating the research and development, manufacturing and sales of pharmaceutical equipment. In addition to the production of conventional pharmaceutical equipment, it provides high-quality services that integrate "pharmaceutical technology, pharmaceutical equipment, and pharmaceutical engineering" ; at the same time, it provides a complete package of services for the construction of chemical, biological and plant medicine factories to solve all worries for customers. In the field of medical services, Xinhua Medical continues to improve its brand competitiveness and reputation. With professional investment, construction, operation, procurement and service platforms, we will build a modern hospital group with advanced medical concepts, cutting-edge scientific research level, brand management chains, and organic integration of resources. In the future, Xinhua Medical will provide more patients with a new look of groupization, specialization and standardization, and achieve the grand dream of developing the health industry. In the medical and trade sector, Xinhua Medical actively responds to new market patterns and changes, maintains the company's sustained competitiveness and healthy development vitality, and explores and innovates business models, aiming to build domestic marketing, international trade, e-commerce, and trade logistics into one. The new marketing pattern fully releases the potential for marketing effectiveness and transforms into new models and new business forms. Be healthy and be honest in the world. Standing at a new historical starting point and facing new development opportunities, Xinhua Medical will continue to keep pace with the times, and bravely face difficulties and challenges with confidence, innovation and hard work, for the cause of human health and for the creation of Chinese medical devices. Continue to work hard to build a world-renowned medical device manufacturer!

Pocos International Medical Trading (Shanghai) Co., Ltd.

Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.

Berlang Medical (Shanghai) International Trade Co., Ltd.

The Berlan Group was founded in 1839 in the Meltsonggen region of Germany, with more than 66,000 employees in 64 countries around the world. After nearly two centuries of ups and downs and silent inheritance by several generations, Berlan has become the world's advanced medical equipment, medical products and services provider today, committed to infusion, anesthesia, dialysis, neurosurgery, spinal surgery, Provide solutions in related treatment areas such as diabetes care, clinical nutrition, wound management, infection prevention, etc. By having constructive dialogue with customers and partners, Berlan continuously develops high-quality innovative products and services for the healthcare system, thereby protecting and improving the health of human beings around the world. In 1985, Berlan established a branch in Hong Kong, China and officially launched its business in Greater China. After more than 30 years of development, Berlan has seven independent legal entities in China, headquartered in Shanghai, with branches in major Chinese cities such as Beijing, Guangzhou, and Wuhan. Its business covers more than 70 cities across the country and is in Jiangsu. Suzhou and Zibo, Shandong have invested in the construction of large production bases.

Zhejiang Daji Medical Devices Co., Ltd.

Zhejiang Daji Medical Equipment Co., Ltd. is located in Shangyu, Zhejiang. It has a superior geographical location and convenient transportation. The company is bordered by National Highway 329 and Hangzhou-Ningbo Canal in the east, connected to Shaoxing by Hangzhou-Ningbo Expressway and National Highway 104 in the west, and connected to Shaoxing's only 10,000-ton terminal - Shangyu Port in the north, and the Shanghai-Hangzhou-Ningbo Railway runs through the territory. The company currently has two pillar products. The first is medical device products. The company is a subsidiary enterprise of the National Family Planning Commission and the Food and Drug Administration. It specializes in the production of four major categories of medical device products, namely (I) Family Planning Devices: IUD, biwing vaginal dilator, and surgical instruments Package, disposable gynecological equipment and other products; (II) Basic surgical instruments: forceps series, scissors series, tweezers series, etc.; (II) Hospital equipment: hospital bed series, gynecological labor bed, instrument table, etc.; (IV) Anal urinary and abdomen Instruments: abdominal hook, analoscope, catheter, etc. The products are sold to family planning committees, pharmaceutical stations, medical device distribution units, and large and traditional Chinese medicine hospitals across the country. Some of them are exported to Europe, America, Southeast Asia and other countries and regions. They have been Alibaba's suppliers for many years. The company has strong production capacity and rich product specifications. The second is mechanical hydraulic sealing products, which have long-term good cooperative relationships with European and American customer units. The company was founded in 1983 and now covers an area of ​​40,000 square meters and has a construction area of ​​more than 40,000 square meters. Among the company's employees, 20% of the junior professional titles account for 20%, and 5% of the middle and senior technical personnel account for 5%. The production equipment is complete, the management system is perfect, the technical strength is strong, and the ability to produce products in one-stop. The company has passed the ISO9001 and 13485 quality system certification. And some products have passed CE certification. The company has always won wide praise from the majority of user units for its advanced equipment, excellent product performance, stable and reliable product quality, timely and thoughtful after-sales service. The company is willing to exchange and cooperate with knowledgeable people from all walks of life in China and abroad under the principles of friendship, equality, honesty, trustworthiness and mutual benefit, so as to jointly open up a bright future!

Nanwei Medical Technology Co., Ltd.

Nanwei Medical Technology Co., Ltd. was founded in 2000. The company is mainly engaged in the research, development, manufacturing and sales of minimally invasive medical devices. Adhering to the purpose of "serving clinical practice with technology and innovation", we are committed to providing high-quality products and services to medical institutions around the world, helping all over the world improve medical level, reduce patient pain, and reduce medical costs. After nearly 20 years of innovative development, the company has gradually moved from a single non-vascular stent product to three major technology platforms, mainly from the domestic market to the domestic and international markets, and has become a high scientific research and innovation strength and core in the field of minimally invasive diagnosis and treatment. Product competitive advantage, industry leading company with rapid growth in performance. The company has undertaken three national scientific research projects, owned 36 domestic and foreign invention patents, obtained 28 registration certificates for Class III medical devices and 45 registration certificates for Class II medical devices. It has successively won the honorary titles of National Torch Program Key High-tech Enterprise, Jiangsu Province Science and Technology Small and Medium-sized Enterprise, Jiangsu Province Key R&D Institution, Jiangsu Province Private Science and Technology Enterprise, etc. The company's core products have competitive advantages. The company's main products include two main product series of endoscopic minimally invasive diagnostic and treatment devices and tumor ablation equipment. The company's newly developed endoscopic optical coherence tomography system (EOCT) has been obtained from the company's endoscopic minimally invasive diagnostic and treatment device product application. In the clinical diagnosis and treatment of digestive and respiratory diseases, it includes six sub-series of products, providing a systematic solution for endoscopic diagnosis and treatment. Among them, the technology that can carry 125I radiation therapy particle stent technology was rated as the world's first, and the main equipment for tumor ablation In order to perform precise microwave ablation of tumors, it has become one of the mainstream medical methods in the field of liver cancer treatment; EOCT is mainly used in conjunction with endoscopy and can be used for early cancer screening and surgical planning, and is expected to develop into the main means of "non-invasive optical biopsy". . The domestic and international markets drive the development of the company. In the domestic market, the company's endoscopic diagnosis and treatment technology products have played a strong role in import substitution, effectively reducing the cost of endoscopic diagnosis and treatment and reducing the burden on patients. The company's products have been sold to more than 2,900 hospitals across the country, and the coverage rate of Grade A hospitals has reached more than 55%. In terms of foreign markets, the company has subsidiaries in the United States and Germany, and its products have passed the approval of the US FDA and the EU CE certification. The products are exported to more than 70 countries and regions including developed countries such as the United States, Germany, Canada, and Japan. From 2016 to 2018, the company's sales revenue reached an average annual compound growth rate, with a growth rate far higher than the industry level. In order to maintain sustained growth, the company has strategically laid out its EOCT system with cutting-edge technical standards. It is the second product in the world to be approved by the US FDA. It is currently conducting clinical research in the Mayo Clinic, Stanford University Hospital Medical Center and other institutions in the United States. It is the company. An important growth point for future business development. In the future, the company will continue to focus on the core capability of transforming medical innovation achievements, continue to grow bigger and stronger, and enter the new minimally invasive diagnosis and treatment field in a timely manner in the future, striving to make the company a global leader in the minimally invasive diagnosis and treatment field.

Smith & Nephew Medical Products International Trade (Shanghai) Co., Ltd.

Smith+Nephew is a multinational medical device manufacturing company headquartered in London, UK. Founded in 1856, the company eliminates restrictions in life through design and production technology. It operates in more than 100 countries around the world and has more than 16,000 employees worldwide. Xerox is a member of the UK's FTSE100 and is listed on the London Stock Exchange and the New York Stock Exchange in the United States. Xerox's main businesses include orthopedics, sports medicine and ear, nose, throat (ENT) and advanced wound management products. In the orthopedic business, the company offers a range of hip and knee implants for replacing diseased, damaged or worn joints, robot-assisted empowerment technologies to enhance surgeons’ capabilities, and for severe fractures and correcting bone deformities. trauma products. In sports medicine and ENT businesses, the company provides advanced products and instruments for repairing or removing soft tissue. In addition, Xerox’s advanced wound management portfolio offers a comprehensive suite of solutions to meet a wide range of and complex clinical needs, committed to helping healthcare professionals keep moving closer to “zero” aspects of the human and economic impact of wounds. Target.

Yuyue Medical Equipment and Supply Co., Ltd.

Jinzhong brand surgical instruments were officially classified as Yuyue Medical in April 2015. With the full support of Yuyue Medical, they spent tens of millions to build an internationally advanced digital production line. Adhering to the concept of "quality creates a brand" and "thinking for users and doing better", Jinzhong brand surgical instruments will break free from the constraints of the mechanism, stimulate infinite enterprising spirit and creativity, and be determined to become a larger scale and higher level. , a leading brand of Chinese surgical instruments with richer products. There are more than 14,000 varieties of King Kong surgical instruments, covering almost all clinical subjects. The King Kong brand surgical instruments mainly include: basic equipment (such as: medical scissors, medical forceps, medical forceps, etc.), specialized equipment (such as: neurosurgery, ophthalmology, otolaryngology, oral department, thoracic surgery, general surgery, hepatobiliary surgery, Urology, anorectal surgery, obstetrics and gynecology, pediatrics, orthopedics, microsurgery, plastic surgery, etc.), complete set of surgical instrument packages (such as: basic surgical instrument packages, specialized surgical instrument packages, etc.), electric tools (such as: orthopedics and other surgeries various electric drills, chainsaws, etc.) and minimally invasive devices (such as laparoscopic devices, hysteroscopic devices, thoracoscopic devices, etc.). For decades, Jinzhong surgical instruments have dominated the domestic market with their strong manufacturing scale and excellent quality. Jinzhong surgical instruments have entered hospitals at all levels with its numerous fancy varieties and good after-sales service.